Uncontrolled cell growth in the tissues of the lung leads to lung cancer. Lung cancer can spread to others parts of the body if left untreated. Long term exposure to tobacco smoke is (general belief) the prime cause of lung cancer. Other causes include exposure to Radon gas, Asbestos and genetic factors. The major symptoms of lung cancer are shortness of breath, coughing up blood, chest pain, hoarse voice and weight loss. Lung cancer is responsible for most cancer related death in men and women worldwide.
But our observation, majority patients suffering from Lung cancer are non smokers.
Recently, we conducted Kaplan-Meier survival analysis curves for our cases of lung cancer treated by the Banerji Protocol exclusively. We compiled our data on lung cancer treated at PBHRF over a 10 year period. Our patients are prescribed only the Banerji Protocols and no other intervention. The average follow-up time of 373 patients seen at PBHRF for this cancer was 15 months, ranging from 6 months to 10 years. Results: Specific survival as regards to complete regression, cases that improved and those that achieved status quo, as well as those who aggravated and also to mention those who expired, show the following percentages: 2% of the cases were completely cured with our therapy. 33% were improved, 25% achieved status quo, while 24% were worse, and 16% died. Mean survival time was 83 months. However, we need to prospectively follow our cases so that we do not lose them to follow-up; this has been a challenge in our effort to accurately document our treatment outcomes. We recently have upgraded our electronic medical records system so that we can more easily retrieve our outcome data, and we are also training staff for the role of research coordinator so that patient compliance and follow-up will be improved and tracked more completely.
At PBHRF, we have been treating various stages of lung cancer.